Skip to Content
Palsonify Logo

Now FDA Approved

Palsonify Logo

Now FDA Approved

GO TO PALSONIFY.COM

Ethics & Compliance

Crinetics Compliance Program

At Crinetics Pharmaceuticals (“Crinetics”), we are committed to operating with integrity and in accordance with the law. As a publicly-traded pharmaceutical company that conducts its business globally, we are subject to various international, federal, state and local laws and regulations. Crinetics has adopted the Compliance Program to assist with complying with these various laws and regulations while maintaining high ethical standards. The Compliance Program applies to our officers, directors, employees, and in certain situations, our agents and independent contractors. It is our expectation that compliance with the Compliance Program and the policies and procedures covered by it are followed. We provide training on the Compliance Program and have established processes for identifying potential violations. In the event that we become aware of violations, we will investigate the matter and, where appropriate, implement corrective measures to prevent future violations.

Our Compliance Program is scalable to address the size, organizational structure and resources of our Company and will continue to evolve accordingly. We regularly monitor and reassess the Compliance Program as well as the policies and procedures covered by it. Crinetics’ Board of Directors may amend or supplement our Compliance Program at any time.

Described below are the fundamental elements of the Compliance Program that include the seven elements that are covered by the Compliance Program Guidance for Pharmaceutical Manufacturers published by the Office of the Inspector General, U.S. Department of Health and Human Services (“OIG Guidance”).

Fundamental Elements of the Compliance Program

Crinetics has appointed a Compliance Officer who is responsible for developing, operating and monitoring the Compliance Program and is advised regularly by the Crinetics Compliance Committee. The Compliance Officer reports directly to the Chief Legal Officer and has direct access to other members of Crinetics’ senior management and the Board of Directors. The Compliance Officer provides a compliance update to the Board of Directors at the regularly scheduled Board meetings and on an as-needed basis.

Crinetics has established a Compliance Committee to advise the Compliance Officer and assist in the implementation of the Compliance Program. The Compliance Committee is comprised of members from functional units across the Company and meets on a regular basis to consider compliance and policy issues encountered in the various business areas.

Crinetics has established written policies and procedures to ensure compliance with various laws and regulations. The standards set forth in these policies and procedures outline our commitment to compliance and corporate accountability and apply to individuals based on their job function and responsibilities.

Crinetics has policies and procedures in place that address risk areas identified in the OIG Guidance and comply with the Pharmaceutical Research and Manufacturers of America voluntary “Code on Interactions with Healthcare Professionals” (the “PhRMA Code”).

Crinetics has also established spend parameters, which include an annual upper dollar limit of $2,500 on meals or promotional items directly towards an individual California healthcare professional (HCP). We track and monitor these spending parameters to the best of our ability, using available resources, and will modify such parameters, if necessary. On rare occasions, management may authorize additional spending based on specific circumstances.

Crinetics has developed general compliance training on the Compliance Program and the Code of Conduct and Ethics as well as applicable training on policies and procedures applicable to the job function and role of the individuals. Training includes how to report compliance concerns through appropriate channels, including reporting anonymously either online or via telephone.

Crinetics has established a variety of internal communication tools for communicating compliance issues and concerns. Individuals are required to report known or suspected violations of laws, or the Crinetics’ policies and procedures, to their direct managers or the Compliance Officer. Any reported information will remain confidential to the extent possible consistent with law and our need to investigate the potential violation. We will not retaliate or take adverse action against anyone who, in good faith, seeks help or who reports known or suspected violations. If the individual who reports a violation is directly involved in the violation, the fact that they reported the violation will be given appropriate consideration in any resulting action.

While individuals are encouraged to speak with their direct manager or to the Compliance Officer, those who wish to anonymously raise concerns about potential violations of law or our policies and procedures may do so either online or via telephone through our EthicsPoint Helpline. Reports will be forwarded to the Compliance Officer for response or investigation.

Crinetics will conduct auditing and monitoring activities designed to assess compliance with the Compliance Program and our various policies and procedures. The nature and frequency of these activities varies according to a variety of factors, including new regulatory requirements. Results are reported to the Compliance Committee.

It is the Crinetics’ policy to respond promptly to violations of law or our policies and procedures and take appropriate action. While each situation will be considered on a case-by-case basis, Crinetics is committed to taking appropriate action to address the violation and deter any future violations. Disciplinary action for non-compliance may include a broad range of disciplinary measures, up to and including termination of employment or a service agreement.

We respond promptly to potential violations of law or Crinetics policies and procedures. The Compliance Officer oversees the investigations process, and the response and level of investigation depends on the reported or detected issue. We will assess whether disciplinary action is appropriate, and whether a violation is due in part to gaps in our policies, procedures, training or internal controls, and take action to prevent future violations.

Crinetics Annual Declaration for California Compliance Program

Based on a good faith understanding of the statutory requirements, the Comprehensive Compliance Program of Crinetics Pharmaceuticals, Inc. (“Crinetics”) meets the requirements of California Health and Safety Code sections 119400-119402.

Crinetics Comprehensive Compliance Program is aligned with: (1) the United States Department of Health and Human Services, Office of Inspector General’s April 2003 “Compliance Program Guidance for Pharmaceutical Manufacturers”; and (2) the Pharmaceutical Research and Manufacturers of America’s “Code on Interactions with Health Care Professionals.”

Crinetics requires all employees to comply with its Code of Business Conduct and Ethics and Crinetics’ policies and procedures. Crinetics’ Comprehensive Compliance Program has been designed to prevent and detect violations of company policy or law. In the event Crinetics becomes aware of potential violations, Crinetics will, where appropriate, take steps to investigate the matter, pursue disciplinary action, and/or implement corrective measures to prevent future violations.

Crinetics has established an annual aggregate dollar limit of $2,500 per California licensed healthcare professional for the following items:

  1. meals provided in connection with educational presentations or scientific exchange; and
  2. educational items intended to enhance patient care.

Copies of this declaration and our Comprehensive Compliance Program are available to view on our corporate website and can be requested by calling the EthicsPoint Helpline at (844-235-9720) or Crinetics’ Compliance department at ([email protected]).

Date: October 28, 2025

 

State Disclosures

In accordance with state laws, Crinetics Pharmaceuticals is disclosing this information in the form required.

Vermont Pharmaceutical Marketer Price Disclosure

Wholesale Acquisition Cost Information for Colorado Prescribers

Wholesale Acquisition Cost Information for Connecticut Prescribing Practitioners and Pharmacists